Open Surgery for Necrotizing Pancreatitis

Pancreatitis,Acute Necrotizing Clinical Trial

Official title:

Open Surgery for Necrotizing Pancreatitis in the Era of Minimally Invasive Approach: 10-year Experience in a High-volume Centre

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04673552
• Other study ID #: denimsur1974
• Status: Completed
• Start date: January 1, 2008
• Est. completion date: February 12, 2020

Study information

• Verified date: March 2024
• Source: Northern State Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Retrospective analysis of the cases of traditional open surgery for acute necrotizing pancreatitis, with evaluation of indications for surgery, intraoperative findings, mortality rate and risk factors of mortality.

Description:

All cases of laparotomy/lumbotomy will be retrospectively analysed, with evaluation of mortality, complications, in-hospital stay, indications for surgery, findings during operation, combination with minimally invasive procedures (radiological drainage, necrosectomy). Assessment of risk factors, like erosive bleeding, intraperitoneal perforation of collection, gut resection, splenectomy, relaparotomy will be done.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 146
• Est. completion date: February 12, 2020
• Est. primary completion date: December 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• laparotomy or lumbotomy performed for acute necrotizing pancreatitis from January, 2008 to December, 2017

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Pancreatitis
• Pancreatitis, Acute Necrotizing
• Pancreatitis,Acute Necrotizing

Intervention

Procedure:
• laparotomy
Any open procedure such as laparotomy or lumbotomy for acute necrotizing pancreatitis will be evaluated, with assessment of results, complications and deaths

Locations

Country	Name	City	State
Russian Federation	Northern State Medical University	Arkhangel'sk	Arkhangelsk Region

Sponsors (1)

Lead Sponsor	Collaborator
Northern State Medical University

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	survival	patient's discharge from the hospital	01.001.2008 - 31.12.2017
Primary	death	patient's death after the surgery	01.001.2008 - 31.12.2017